Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma (ARCHED)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05820841 |
|
Recruitment Status :
Recruiting
First Posted : April 20, 2023
Last Update Posted : August 31, 2023
|
Sponsor:
Universität des Saarlandes
Collaborators:
University of Leipzig
University Hospital Regensburg
Wuerzburg University Hospital
University Hospital of Gießen and Marburg
Saarland University Medical Center
AstraZeneca
Information provided by (Responsible Party):
Universität des Saarlandes
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 2028 |
| Estimated Study Completion Date : | December 2028 |